NSEGeneral Updates4d ago · 5 Nov 2026, 06:11 pm
General Updates
AstraZeneca Pharma India Limited · ASTRAZEN
✦ AI SummaryMgmt Change
AstraZeneca Pharma India Limited has informed the Exchange about General Updates, specifically the determination of materiality - Details of Key Managerial Personnel.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
ASTRAZEN_05112026181111_Determination_of_Meteriality_under_Reg_30.pdf
View document text
November 5, 2026
The Manager - Listing
BSE Limited
P J Towers, Dalal Street, Fort
Mumbai - 400 001
BSE scrip code: 506820
The Manager - Listing
National Stock Exchange of India Limited
Exchange Plaza,
Bandra – Kurla Complex, Bandra (E)
Mumbai - 400 051
NSE symbol: ASTRAZEN
Dear Sir/ Madam,
Subject: Determination of materiality - Details of Key Managerial Personnel
This is to inform that, as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, the contact details of the Key Managerial Personnel authorised to determine the
materiality of an event and/or information for disclosure to the Stock Exchange(s), with effect from November 9,
2026, are as follows:
Sl. No. Name & Designation Contact Details
1. Mr. Praveen Rao Akkinepally Praveen.Akkinepally@astrazeneca.com
Managing Director
2. Mr. Atul Tandon Atul.Tandon@astrazeneca.com
Chief Financial Officer
3. Ms. Tanya Sanish tanya.sanish@astrazeneca.com
Company Secretary
Kindly take the above information on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer
ACS No. A25784